Organization Profile

You just read:

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN®

News provided by

Concordia Healthcare Corp.

Oct 07, 2014, 07:00 ET